These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20158087)

  • 1. [Anti-atherosclerotic effects by PPARgamma and its ligands through the activation of reverse cholesterol transport system].
    Wakino S; Itoh H
    Nihon Rinsho; 2010 Feb; 68(2):217-23. PubMed ID: 20158087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ; Usher MG; Mortensen RM
    Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
    Ogawa D; Nomiyama T; Nakamachi T; Heywood EB; Stone JF; Berger JP; Law RE; Bruemmer D
    Circ Res; 2006 Apr; 98(7):e50-9. PubMed ID: 16556873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective role of PPARgamma agonists against cardiovascular disease].
    Yamagishi S
    Nihon Rinsho; 2010 Feb; 68(2):307-11. PubMed ID: 20158101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PPARgamma and cancer].
    Nakagama H
    Nihon Rinsho; 2010 Feb; 68(2):323-9. PubMed ID: 20158104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of PPARgamma agonist on dyslipidemia and atherosclerosis].
    Komatsu A; Node K
    Nihon Rinsho; 2010 Feb; 68(2):294-8. PubMed ID: 20158099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG; Hele DJ; Birrell MA
    Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
    Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
    J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders.
    Heneka MT; Landreth GE; Hüll M
    Nat Clin Pract Neurol; 2007 Sep; 3(9):496-504. PubMed ID: 17805244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
    Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
    Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
    Park SJ; Lee YC
    J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma (PPARgamma): Is the genomic activity the only answer?
    Luconi M; Cantini G; Serio M
    Steroids; 2010; 75(8-9):585-94. PubMed ID: 19900469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma and its ligands in controlling interleukin-1beta target gene expression: a confusing story.
    François M; Richette P; Corvol MT
    Drug News Perspect; 2005 May; 18(4):257-61. PubMed ID: 16034482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
    Abdelrahman M; Sivarajah A; Thiemermann C
    Cardiovasc Res; 2005 Mar; 65(4):772-81. PubMed ID: 15721857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of PPARgamma in the control of prostate cancer growth: a new approach for therapy].
    Annicotte JS; Culine S; Fajas L
    Bull Cancer; 2007 Feb; 94(2):135-7. PubMed ID: 17337382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The many faces of PPARgamma: anti-inflammatory by any means?
    Szanto A; Nagy L
    Immunobiology; 2008; 213(9-10):789-803. PubMed ID: 18926294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-atherosclerotic effects of PPAR gamma ligands].
    Wakino S
    Nihon Rinsho; 2004 Jan; 62(1):180-6. PubMed ID: 14737851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components.
    Martin H
    Mutat Res; 2009 Oct; 669(1-2):1-7. PubMed ID: 19563816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular effects of PPARgamma activators - from bench to bedside.
    Marx N; Walcher D
    Prog Lipid Res; 2007 Nov; 46(6):283-96. PubMed ID: 17637478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.